Does imidazole-based alkaloid derivative LCB54-0009 suppress ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization?
LCB54-0009 is a potential candidate molecule for blocking pathological angiogenesis and lymphangiogenesis mediated by HIF-1α- angiopoietin-2 expression and VEGFR-2 activation.
Akinesia algera is by primary source to be evaluated as a coenästhetic symptom and remains in daily practice a diagnostic challenge.